WallStreetZenWallStreetZen

NASDAQ: ONTX
Onconova Therapeutics Inc Earnings & Revenue

ONTX past revenue growth

How has ONTX's revenue growth performed historically?
Company
0%
Industry
169.3%
Market
17.86%
ONTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ONTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ONTX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ONTX earnings and revenue history

Current Revenue
$226.0k
Current Earnings
-$20.2M
Current Profit Margin
-8,931%

ONTX Return on Equity

Current Company
-95.4%
Current Industry
15.4%
Current Market
-8.4%
ONTX's Return on Equity (-95.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ONTX announces earnings.

ONTX Return on Assets

Current Company
-61.2%
Current Industry
2.2%
ONTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ONTX Return on Capital Employed

Current Company
-116.24%
Current Industry
17.7%
ONTX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ONTX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ONTX$226.00k-$20.17M-$20.18M-29.65%N/A
CLDI$0.00-$26.88M-$29.22M-100.00%N/A
PMCB$0.00-$1.14M-$11.51MN/AN/A
SYBX$3.37M-$51.97M-$57.28M+5.99%N/A
ITRM$0.00-$27.84M-$31.10M-100.00%N/A

ONTX earnings dates

Next earnings date
May 13, 2024

Onconova Therapeutics Earnings & Revenue FAQ

What were ONTX's earnings last quarter?

On Invalid Date, Onconova Therapeutics (NASDAQ: ONTX) reported Q3 2023 earnings per share (EPS) of -$0.23, up 11.54% year over year. Total Onconova Therapeutics earnings for the quarter were -$4.74 million. In the same quarter last year, Onconova Therapeutics's earnings per share (EPS) was -$0.26.

If you're new to stock investing, here's how to buy Onconova Therapeutics stock.

What was ONTX's earnings growth in the past year?

As of Q1 2024, Onconova Therapeutics's earnings has grown year over year. Onconova Therapeutics's earnings in the past year totalled -$20.18 million.

What is ONTX's earnings date?

Onconova Therapeutics's earnings date is Invalid Date. Add ONTX to your watchlist to be reminded of ONTX's next earnings announcement.

What was ONTX's revenue last quarter?

On Invalid Date, Onconova Therapeutics (NASDAQ: ONTX) reported Q3 2023 revenue of $57.00 thousand up 0% year over year. In the same quarter last year, Onconova Therapeutics's revenue was $57.00 thousand.

What was ONTX's revenue growth in the past year?

As of Q1 2024, Onconova Therapeutics's revenue has grown 0% year over year. This is 169.3 percentage points lower than the US Biotechnology industry revenue growth rate of 169.3%. Onconova Therapeutics's revenue in the past year totalled $226.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.